Publications found:
33,058
Sort by:
Pharmaceutical Industry in Norway
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Norway. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Norway – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Taiwan
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Taiwan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Taiwan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Hungary
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Hungary. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Hungary – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Belgium
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Belgium. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Belgium – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Germany
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Germany. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Germany – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Russia
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Russia. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Russia – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Czech Republic
US$ 300.00
... complete analysis of the Pharmaceutical Industry in Czech Republic. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in Czech Republic – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in South Africa
US$ 300.00
... complete analysis of the Pharmaceutical Industry in South Africa. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in South Africa – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Italy
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Italy. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Italy – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Meeting KOL Needs: What Pharma Needs to Know
US$ 1,445.00
The role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's about to change again.Once viewed with suspicion by their non-consulting peers, clinicians are now considered less...
January 2012
108 pages
Outsourcing in Drug Development: The Contract Research (Clinical Trial ) Market
US$ 3,995.00
... can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to ... (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion ...
January 2012
235 pages
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
US$ 2,635.00
... presentations. You will find answers in our work. Revenue forecasts, market shares, developmental trends, discussions and interviews In the report you ... charts and four research interviews. Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work In particular, this study ...
January 2012
120 pages
China Chemical Pharmaceutical Industry Report, 2011
US$ 2,300.00
In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...
January 2012
112 pages
Academic Detailing: Pharma Fights Back
US$ 745.00
Ever since it was introduced three decades ago, academic detailing—which now increasingly uses pharma’s sales techniques to educate physicians—has posed a difficult issue for the industry. Governed by...
January 2012
35 pages
China Pharmaceutical Chain Industry Report, 2011
US$ 1,800.00
In China, the pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20% drugs are sold to consumers through pharmaceutical retail...
December 2011
76 pages
Pharmaceuticals: Market Research Report
US$ 1,995.00
... also recapitulates recent noteworthy mergers, acquisitions, and other strategic developments. The report briefly discusses the pharmaceutical market outlook across various markets worldwide. Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South ...
December 2011
443 pages
Global Pharmaceutical & Biotechnology Outlook 2012
US$ 12,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2011
466 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages
Generic Drug Market in Canada
US$ 1,000.00
Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...
November 2011
65 pages
Multiple Sclerosis Treatment: World Drug Market 2012-2022
US$ 2,635.00
... tables and charts and three research interviews. Advantages of Multiple Sclerosis Treatment: World Drug Market 2012-2022 for your work Our ... , viewing sales growth Discover revenue forecasts to 2022 for leading MS drugs, assessing commercial potential Assess leading companies, discovering their activities ...
November 2011
116 pages
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition
US$ 800.00
... chronic condition has also risen. The report analyzes the US Pharmacy Benefit Management Industry. Rising drug prices, increasing drug utilization and prevalence ... , contracts for renewals of the major players and market share of PBM companies adjusted on the basis of acquisitions and contract shifts. This ...
November 2011
40 pages
Pharma Product Launches: Strategies for Success
US$ 595.00
Failed launches. It sounds a bit harsh, yet when it comes to new product launches, that has increasingly been the pharmaceutical industry’s experience since the recession. A tighter economic climate,...
October 2011
30 pages
Vaccine Pipeline Database: 1-Year Subscription
US$ 1,333.00
Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use ...
October 2011
274 pages
Competitor Analysis HIV Vaccines
US$ 413.00
... (plasmid, conventional, alternative delivery and prime – boost regimens) Adenoviral vector vaccines Poxvirus vector vaccines Protein & peptide vaccines Others Corporate HIV Vaccine R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise ...
October 2011
54 pages
The UK Vitamin and Dietary Supplements Demand and Forecast
US$ 630.00
Executive summary The UK is one of the developed countries of Western Europe and has a well-formed nutrients & supplements market in the world. The industry has been registering growth primarily...
September 2011
36 pages
The 2011 Global Pharmaceutical Market Dynamics and Trends
US$ 1,480.00
A 25-page worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for key geographic regions: North America, Europe, Japan, Latin America. Sales ...
September 2011
25 pages
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ...
September 2011
1353 pages
North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the North American pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Global CNS Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
Global Oncology Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Oncology Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Emergency Contraception in Ukraine
US$ 990.00
... simply unable to afford emergency contraception, particularly as unregulated prices resulted in a wide variance in price across chemists/pharmacies. Euromonitor International's Emergency Contraception in Ukraine report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
September 2011
19 pages